Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers
Tatiana Kamaletdinova, Zahra Fanaei‐Kahrani, Zhao‐Qi Wang
Cells (2019) Vol. 8, Iss. 12, pp. 1625-1625
Open Access | Times Cited: 133

Showing 26-50 of 133 citing articles:

PARP inhibitor resistance in ovarian cancer: Underlying mechanisms and therapeutic approaches targeting the ATR/CHK1 pathway
Łukasz Biegała, Arkadiusz Gajek, Agnieszka Marczak, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188633-188633
Open Access | Times Cited: 32
Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaks
Uday Kiran Velagapudi, Élise Rouleau-Turcotte, Ramya Billur, et al.
Biochemical Journal (2024) Vol. 481, Iss. 6, pp. 437-460
Open Access | Times Cited: 4
Exploring the role of parthanatos in CNS injury: Molecular insights and therapeutic approaches
Jiacheng Zhang, Xinli Hu, Yibo Geng, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 4
Single-molecule analysis of PARP1-G-quadruplex interaction
Paras Gaur, Fletcher E. Bain, Riaz Meah, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Blast‐Overpressure Induced Modulation of PARP‐SIRT‐NRF2 Axis in Stress Signaling of Astrocytes and Microglia
Vijaya Prakash Krishnan Muthaiah, Kathiravan Kaliyappan, Ramkumar Thiayagarajan, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 1
Open Access
Impact of a Cancer-Associated Mutation on Poly(ADP-ribose) Polymerase1 Inhibition
Naga Shanmugam, Shubham Chatterjee, G. Andrés Cisneros
The Journal of Physical Chemistry B (2025)
Open Access
XRCC1 mediates PARP1- and PAR-dependent recruitment of PARP2 to DNA damage sites
Xiaohui Lin, Kay Sze Karina Leung, Kaitlynn F. Wolfe, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 4
Open Access
Caspase 3 and caspase 7 promote cytoprotective autophagy and the DNA damage response during non-lethal stress conditions in human breast cancer cells
Gayathri Samarasekera, Nancy E. Go, Courtney Choutka, et al.
PLoS Biology (2025) Vol. 23, Iss. 3, pp. e3003034-e3003034
Open Access
The PARP1-Siah1 Axis Controls HIV-1 Transcription and Expression of Siah1 Substrates
Dan Yu, Rongdiao Liu, Geng Yang, et al.
Cell Reports (2018) Vol. 23, Iss. 13, pp. 3741-3749
Open Access | Times Cited: 33
PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?
Angela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, et al.
Medicines (2020) Vol. 7, Iss. 9, pp. 54-54
Open Access | Times Cited: 28
PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis
Weronika Wasyluk, Agnieszka Zwolak
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 1827-1844
Open Access | Times Cited: 25
Poly (ADP-ribose) polymerase 1 promotes HuR/ELAVL1 cytoplasmic localization and inflammatory gene expression by regulating p38 MAPK activity
Xingyue Fu, Jiaqi Zhang, Keke Sun, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Divalent and multivalent cations control liquid-like assembly of poly(ADP-ribosyl)ated PARP1 into multimolecular associates in vitro
Maria V. Sukhanova, Rashid O. Anarbaev, Ekaterina A. Maltseva, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Poly ADP-ribose signaling is dysregulated in Huntington disease
Tamara Maiuri, Carlos Barba Bazan, Rachel Harding, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 40
Closed Access | Times Cited: 3
Role of PARP-1 structural and functional features in PARP-1 inhibitors development
Alexander Vladimirovich Merkuryev, Egorov Vv
Bioorganic Chemistry (2025) Vol. 156, pp. 108188-108188
Closed Access
Targeting DNA repair mechanisms: Spirobenzoxazinone and salicylamide derivatives as novel candidates for PARP-1 inhibition in cancer therapy
Abdelrazak M. Kadry, Mai Adel, Samar A. Abubshait, et al.
Bioorganic & Medicinal Chemistry (2025), pp. 118173-118173
Closed Access
A large-scale method to measure the absolute stoichiometries of protein Poly-ADP-Ribosylation
Peng Li, Yajie Zhang, Yonghao Yu
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Discovery of a Novel [6–6–5–5–6] Pentacyclic Tetrahydrocyclopentaphthalazinone as a Promising PARP Inhibitor Scaffold
Yagmur U. Doruk, Morgan E. Diolaiti, Alan Ashworth, et al.
ACS Medicinal Chemistry Letters (2025)
Closed Access
The function and regulation of ADP-ribosylation in the DNA damage response
Lena Duma, Ivan Ahel
Biochemical Society Transactions (2023) Vol. 51, Iss. 3, pp. 995-1008
Open Access | Times Cited: 8
PARP1-dependent DNA-protein crosslink repair
Zita Fábián, Ellen S. Kakulidis, Ivo A. Hendriks, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Proton and photon radiosensitization effects of niraparib, a PARP‐1/‐2 inhibitor, on human head and neck cancer cells
Li Wang, Jianzhong Cao, Xiaochun Wang, et al.
Head & Neck (2020) Vol. 42, Iss. 9, pp. 2244-2256
Closed Access | Times Cited: 23
Development of Next-Generation Poly(ADP-Ribose) Polymerase 1–Selective Inhibitors
Natalie Ngoi, Elisabetta Leo, Mark J. O’Connor, et al.
The Cancer Journal (2021) Vol. 27, Iss. 6, pp. 521-528
Closed Access | Times Cited: 18
DNA Methylation Malleability and Dysregulation in Cancer Progression: Understanding the Role of PARP1
Rakesh Srivastava, Niraj Lodhi
Biomolecules (2022) Vol. 12, Iss. 3, pp. 417-417
Open Access | Times Cited: 13
Small molecule tractable PARP inhibitors: Scaffold construction approaches, mechanistic insights and structure activity relationship
Amandeep Thakur, Mandeep Rana, Ritika Ritika, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106893-106893
Closed Access | Times Cited: 7
Paclitaxel induces human KOSC3 oral cancer cell apoptosis through caspase pathways
Yu-Yan Lan, TSUN-CHIH CHENG, Yi-Ping Lee, et al.
Biocell (2024) Vol. 48, Iss. 7, pp. 1047-1054
Open Access | Times Cited: 2

Scroll to top